The peculiarities of changes in myocardial electrical activity and heart rate variability in patients with coronary artery disease depending on the stage of concomitant iron deficiency

Authors

DOI:

https://doi.org/10.14739/2310-1210.2023.6.284802

Keywords:

coronary artery disease, latent iron deficiency, anemia, myocardial electrical activity, autonomic dysfunction, ferrokinetic

Abstract

The aim of the study: to assess changes in myocardial electrical activity and heart rate variability (HRV) in patients with coronary artery disease (CAD) depending on the stage of iron deficiency (ID) and identify their relationship with ferrokinetic parameters.

Materials and methods. In total, 90 patients with CAD, stable angina II–III FC were examined (men – 35, women – 55, age – 69 (61; 72) years). The patients were divided into 4 groups: the 1st group (n = 16) consisted of patients with concomitant ID anemia (IDA) of mild and moderate severity, the 2nd (n = 15) – with latent ID, the 3rd (n = 14) – with functional ID, the 4th (n = 45) – patients with CAD without iron metabolism disorders. The HRV features during 24 hours, daytime and nighttime as well as their relationships with ferrokinetic and hematological parameters were analyzed. The data analysis was performed using Statistica 13.0.

Results. CAD patients with concomitant IDA demonstrated a tendency to have a higher average daytime heart rate value (U = 14.0; p ≈ 0.08), a longer duration of tachycardia (U = 20.0; p ≈ 0.06), and a significantly greater number (2.4 times) of ventricular extrasystoles (VE) (U = 7.0; p < 0.05) compared to patients without iron metabolism disorders. There were no statistically significant differences in heart rate, episodes of tachycardia, and the number of arrhythmic events in CAD patients with different stages of ID. During the temporal analysis of HRV indicators, patients with different stages of concomitant ID demonstrated a decrease in overall HRV due to SDNN-index, rMSSD (%) and HRVT triangular index both in active and passive periods as compared to patients without iron metabolism disorders. Spectral analysis of HRV has revealed reduced parasympathetic activity of the autonomic nervous system due to HF indicator in patients of the 1st–3rd groups. The presence of concomitant IDA was characterized by maximum changes in HRV indicators and the predominance of central mechanisms of HRV regulation over autonomic ones, which was confirmed by a significant increase in the centralization index (IC) and stress index (SI). For CAD patients with concomitant IDA and latent ID, a number of relationships between ferrokinetic and HRV parameters was found. There were no statistically significant correlations between indicators of iron metabolism and HRV in patients with CAD and functional ID.

Conclusions. The decrease in iron stores in the body due to its tissue and transport reserves is accompanied by changes in the myocardial electrical activity, a progressive reduction in heart rate variability, autonomic dysfunction towards a suppression of the parasympathetic domain activity, confirming the relevant correlations with the ferrokinetic parameters.

Author Biographies

M. O. Konovalova, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD student in the Department of General Practice (Family Medicine) and Internal Diseases

N.S. Mikhailovska, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, DSc, Professor, Head of the Department of General Practice (Family Medicine) and Internal Diseases

References

Mykhailovska, N. S., Kulynych, T. O., Shershnova, O. V., Bazun, Ye. I., Bocharnykova, I. S., Padafa, V. E., Kolesnykova, A. O., & Hura, Yu. V. (2020). Osoblyvosti klinichnoho ta metabolichnoho profiliu khvorykh na ishemichnu khvorobu sertsia, shcho asotsiiovana z tsukrovym diabetom 2 typu (retrospektyvnyi analiz) [Peculiarities of clinical and metabolic profile of patients with coronary artery disease associated with type 2 diabetes mellitus (retrospective analysis)]. Pathologia, 17(2) (49), 156-163. [in Ukrainian]. https://doi.org/10.14739/2310-1237.2020.2.212754

Shved, M. I., Yurkiv, V. V., Levytska, L. V., & Kashuba, M. I. (2022). Problema komorbidnosti v klinichnii praktytsi kardioloha [The problem of comorbidity in the clinical practice of a cardiologist]. Zdobutky klinichnoi i eksperymentalnoi medytsyny, (2), 21-27. [in Ukrainian]. https://doi.org/10.11603/1811-2471.2022.v.i2.13129

Weidmann, H., Bannasch, J. H., Waldeyer, C., Shrivastava, A., Appelbaum, S., Ojeda-Echevarria, F. M., Schnabel, R., Lackner, K. J., Blankenberg, S., Zeller, T., & Karakas, M. (2020). Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study. Journal of the American Heart Association, 9(9), e015480. https://doi.org/10.1161/JAHA.119.015480

Gupta, K., Kalra, R., Rajapreyar, I., Joly, J. M., Pate, M., Cribbs, M. G., Ather, S., Prabhu, S. D., & Bajaj, N. S. (2020). Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial). The American journal of cardiology, 125(9), 1347-1354. https://doi.org/10.1016/j.amjcard.2020.01.046

Mykhailovska, N. S., & Stetsiuk, I. O. (2022). Vegetative and electrical disorders in women with chronic coronary syndrome depending on the state of bone mineral density. Pathologia, 19(2), 98-103. https://doi.org/10.14739/2310-1237.2022.2.254816

Jibhkate, A., & Lath, R. (2019). Assessing severity of involvement of autonomic functions in iron-deficiency anemia patients. National Journal of Physiology, Pharmacy and Pharmacology, 9(5), 429-433. https://doi.org/10.5455/njppp.2019.9.0307912032019

Avni Findikli, H., & Sahin Tutak, A. (2018). The Effects of Severe Iron Deficiency Anemia on T-wave Intervals. Archives of Clinical and Biomedical Research, 02(06), 233-238. https://doi.org/10.26502/acbr.50170061

Kwon, J. M., Cho, Y., Jeon, K. H., Cho, S., Kim, K. H., Baek, S. D., Jeung, S., Park, J., & Oh, B. H. (2020). A deep learning algorithm to detect anaemia with ECGs: a retrospective, multicentre study. The Lancet. Digital health, 2(7), e358-e367. https://doi.org/10.1016/S2589-7500(20)30108-4

Keskin, M., Ural, D., Altay, S., Argan, O., Börklü, E. B., & Kozan, Ö. (2018). Iron deficiency and hematinic deficiencies in atrial fibrillation: A new insight into comorbidities. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 46(2), 103-110. https://doi.org/10.5543/tkda.2018.51001

Tu, S. J., Hanna-Rivero, N., Elliott, A. D., Clarke, N., Huang, S., Pitman, B. M., Gallagher, C., Linz, D., Mahajan, R., Lau, D. H., Sanders, P., & Wong, C. X. (2021). Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: A systematic review and meta-analysis. Journal of cardiovascular electrophysiology, 32(3), 686-694. https://doi.org/10.1111/jce.14898

Weidner, K., von Zworowsky, M., Schupp, T., Hoppner, J., Kittel, M., Rusnak, J., Kim, S. H., Abumayyaleh, M., Borggrefe, M., Barth, C., Ellguth, D., Taton, G., Reiser, L., Bollow, A., Meininghaus, D. G., Bertsch, T., El-Battrawy, I., Akin, I., & Behnes, M. (2021). Effect of Anemia on the Prognosis of Patients with Ventricular Tachyarrhythmias. The American journal of cardiology, 154, 54-62. https://doi.org/10.1016/j.amjcard.2021.05.045

Ivanov, V. P., Kolesnyk, M. O., Kolesnyk,O. M., & Ivanova, Ye. I. (2018). Anemii v rakursi problemy khronichnoi sertsevoi nedostatnosti: patogenez i laboratorna diagnostyka [Anemia from the perspective of the problem of chronic heart failure: pathogenesis and laboratory diagnosis]. Acta Medica Leopoliensia, 24(2), 69-76. [in Ukrainian]. https://doi.org/10.25040/aml2018.02

Goldberger, J. J., Arora, R., Buckley, U., & Shivkumar, K. (2019). Autonomic Nervous System Dysfunction: JACC Focus Seminar. Journal of the American College of Cardiology, 73(10), 1189-1206. https://doi.org/10.1016/j.jacc.2018.12.064

Bogdanova, N. O., Pogorela, N. H., & Lukyanetz, E. A. (2021). Rol hipoksii u rozvytku deiakykh patolohichnykh staniv ta zloiakisnykh pukhlyn [The role of hypoxia in the development of some pathological conditions and malignant tumors]. Fiziolohichnyi zhurnal, 67(2), 53-66. [in Ukrainian]. https://doi.org/10.15407/fz67.02.053

Stepanova, N. M., Kolesnyk, M. O., Novakivskyi, V. V., Lobodа, O. M., Snisar, L. M., & Shifris, I. M. (2019). Dozozalezhnyi vplyv tryvaloho aktyvatora retseptoriv erytropoetynu na vehetatyvnu rehuliatsiiu sertsevoi diialnosti ta kardiovaskuliarni podii u khvorykh, yaki likuiutsia metodom hemodiafiltratsi [Dose-dependent effect of continuous erythropoietin receptor activator on cardiac autonomic nervous activity and cardiovascular events in patients treated with online hemodiafiltration]. Zaporozhye medical journal, 21(3), 346-354. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2019.3.169112

Yilmaz, E., & Aydin, E. (2021). The effect of low iron storage without Anaemia on electrocardiography. Journal of electrocardiology, 64, 76-79. https://doi.org/10.1016/j.jelectrocard.2020.11.015

Marchitto, N., Curcio, A., Iannarelli, N., Petrucci, A., Romano, A., Pironti, M., Paparello, P. T., & Raimondi, G. (2020). A pilot study on secondary anemia in "frailty" patients treated with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine: safety of treatment explored by HRV non-linear analysis as predictive factor of cardiovascular tolerability. European review for medical and pharmacological sciences, 24(14), 7776-7783. https://doi.org/10.26355/eurrev_202007_22280

Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50. https://doi.org/10.1182/blood-2018-06-856500

Anker, S. D., Kirwan, B. A., van Veldhuisen, D. J., Filippatos, G., Comin-Colet, J., Ruschitzka, F., Lüscher, T. F., Arutyunov, G. P., Motro, M., Mori, C., Roubert, B., Pocock, S. J., & Ponikowski, P. (2018). Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. European journal of heart failure, 20(1), 125-133. https://doi.org/10.1002/ejhf.823

Snook, J., Bhala, N., Beales, I. L. P., Cannings, D., Kightley, C., Logan, R. P., Pritchard, D. M., Sidhu, R., Surgenor, S., Thomas, W., Verma, A. M., & Goddard, A. F. (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut, 70(11), 2030-2051. https://doi.org/10.1136/gutjnl-2021-325210

Konovalova, M. O., & Mykhailovska, N. S. (2023). Vzaiemozviazok ferokinetychnykh pokaznykiv zi stanom kardialnoho remodeliuvannia u khvorykh na ishemichnu khvorobu sertsia iz suputnim zalizodefitsytom [The relationship between ferrokinetic parameters and the state of cardiac remodeling in patients with coronary artery disease with concomitant iron deficiency]. Pathologia, 20(1), 20-26. [in Ukrainian]. https://doi.org/10.14739/2310-1237.2023.1.275370

Bakogiannis, C., Mouselimis, D., Tsarouchas, A., Papadopoulos, C. E., Theofillogiannakos, E. K., Lechat, E., Antoniadis, A. P., Pagourelias, E. D., Kelemanis, I., Tzikas, S., Fragakis, N., Efthimiadis, G. K., Karamitsos, T. D., Doumas, M., & Vassilikos, V. P. (2023). Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE-HF trial. ESC heart failure, 10(2), 1184-1192. https://doi.org/10.1002/ehf2.14276

Khanyukov, O. O., & Zaiats, I. O. (2022). Nitric oxide donators in complex treatment of patients with coronary heart disease and anemia: antiischemic and antiarrhythmic effects. Visnyk problem biolohii i medytsyny, (3), 277-282. https://doi.org/10.29254/2077-4214-2022-3-166-277-282

Melenovsky, V., Petrak, J., Mracek, T., Benes, J., Borlaug, B. A., Nuskova, H., Pluhacek, T., Spatenka, J., Kovalcikova, J., Drahota, Z., Kautzner, J., Pirk, J., & Houstek, J. (2017). Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. European Journal of Heart Failure, 19(4), 522-530. https://doi.org/10.1002/ejhf.640

Bakogiannis, C., Briasoulis, A., Mouselimis, D., Tsarouchas, A., Papageorgiou, N., Papadopoulos, C., Fragakis, N., & Vassilikos, V. (2020). Iron deficiency as therapeutic target in heart failure: a translational approach. Heart failure reviews, 25(2), 173-182. https://doi.org/10.1007/s10741-019-09815-z

Burns, J. A., Sanchez, C., Beussink, L., Daruwalla, V., Freed, B. H., Selvaraj, S., & Shah, S. J. (2018). Lack of Association Between Anemia and Intrinsic Left Ventricular Diastolic Function or Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction. The American journal of cardiology, 122(8), 1359-1365. https://doi.org/10.1016/j.amjcard.2018.06.045

Yamada, S., Yoshihisa, A., Kaneshiro, T., Amami, K., Hijioka, N., Oikawa, M., & Takeishi, Y. (2020). The relationship between red cell distribution width and cardiac autonomic function in heart failure. Journal of Arrhythmia, 36(6), 1076-1082. https://doi.org/10.1002/joa3.12442

Vytrykhovskyi, A. I. (2017). Osoblyvist variabelnosti sertsevoho rytmu patsiientiv z ishemichnoiu khvoroboiu sertsia ta naiavnymy faktoramy ryzyku sertsevo-sudynnykh zakhvoriuvan za shkaloiu Score [Heart rate variability features in patients with coronary heart disease and presence of cardiovascular disease risk factors by the SCORE scale]. Halytskyi likarskyi visnyk, 24(2), 8-12. [in Ukrainian].

Published

2023-12-05

How to Cite

1.
Konovalova MO, Mikhailovska N. The peculiarities of changes in myocardial electrical activity and heart rate variability in patients with coronary artery disease depending on the stage of concomitant iron deficiency. Zaporozhye Medical Journal [Internet]. 2023Dec.5 [cited 2024May19];25(6):493-500. Available from: http://zmj.zsmu.edu.ua/article/view/284802